These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15046624)
1. Correlation studies of plasma paraoxonase activity and uric acid concentration with AAPH-Induced erythrocyte hemolysis in hemodialysis patients. Kirschbaum B Artif Organs; 2004 Mar; 28(3):259-64. PubMed ID: 15046624 [TBL] [Abstract][Full Text] [Related]
2. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Sutherland WH; de Jong SA; Walker RJ Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042 [TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Dirican M; Akca R; Sarandol E; Dilek K J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056 [TBL] [Abstract][Full Text] [Related]
4. Lidocaine inhibits potassium efflux and hemolysis in erythrocytes during oxidative stress in vitro. Lenfant F; Lahet JJ; Vergely C; Volot F; Freysz M; Rochette L Gen Pharmacol; 2000 Mar; 34(3):193-9. PubMed ID: 11120381 [TBL] [Abstract][Full Text] [Related]
5. Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure. Varga É; Seres I; Harangi M; Kárpáti I; Koncsos P; Sztanek F; Paragh G Kidney Blood Press Res; 2012; 35(4):265-72. PubMed ID: 22378349 [TBL] [Abstract][Full Text] [Related]
6. Renal cortical thickness and PON1 activity both decrease in chronic renal failure. Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630 [TBL] [Abstract][Full Text] [Related]
7. alpha-Lipoic acid protects against hemolysis of human erythrocytes induced by peroxyl radicals. Constantinescu A; Tritschler H; Packer L Biochem Mol Biol Int; 1994 Jul; 33(4):669-79. PubMed ID: 7981654 [TBL] [Abstract][Full Text] [Related]
9. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis. Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of free radical-induced erythrocyte hemolysis by 2-O-substituted ascorbic acid derivatives. Takebayashi J; Kaji H; Ichiyama K; Makino K; Gohda E; Yamamoto I; Tai A Free Radic Biol Med; 2007 Oct; 43(8):1156-64. PubMed ID: 17854711 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M; Karry R; Aviram M Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis. Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020 [TBL] [Abstract][Full Text] [Related]
14. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL. Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301 [TBL] [Abstract][Full Text] [Related]
15. Intracellular antioxidant detoxifying effects of diosmetin on 2,2-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation. Liao W; Ning Z; Chen L; Wei Q; Yuan E; Yang J; Ren J J Agric Food Chem; 2014 Aug; 62(34):8648-54. PubMed ID: 25075433 [TBL] [Abstract][Full Text] [Related]
16. Paraoxonase activity in healthy, diabetic, and hemodialysis patients. Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382 [TBL] [Abstract][Full Text] [Related]
17. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515 [TBL] [Abstract][Full Text] [Related]